PATENT CLAIM ANALYSIS

Application Number: 16132857
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "428000"]

Abstract:
The invention provides biodegradable implants sized for implantation in an ocular region and methods for treating medical conditions of the eye. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, and deliver active agents into an ocular region without a high burst release.

Claim (Index 9):
The method of  claim 8 , wherein the ocular region is selected from the group consisting of the anterior chamber, the posterior chamber, the vitreous cavity, the choroid, the suprachoroidal space, the conjunctiva, the subconjunctival space, the episcleral space, the intracorneal space, the epicorneal space, the sclera, the pars plana, surgically-induced avascular regions, the macula and the retina.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.30769
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13213473', '11932101', '13922482', '13797230', '12173746']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8817871678416859
- 35 USC 102 Novelty (BERT): 0.6165424917453947
- Combined Prediction Score: 0.8552627002320567
- Mean Citation Score: 652.9475940000002
- Max Citation Score: 662.87115
- Similarity Product: 503.73323307187553

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test